![Aaron Rosenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Aaron Rosenberg
Directeur Financier/CFO chez
BEIGENE LTD
Fortune : 9 M $ au 30/06/2026
Profil
Aaron Rosenberg is currently Treasurer, Director & Senior Vice President at ArQule, Inc., Treasurer, Director & Senior Vice President at Acceleron Pharma, Inc. since 2021, Treasurer & Director at Harrisvaccines LLC, Treasurer, Director & Senior Vice President at Imago BioSciences, Inc. since 2023, Director at Prometheus Biosciences, Inc. since 2023, and Chief Financial Officer at BeOne Medicines Ltd. since 2024.
Formerly, Mr. Rosenberg was Treasurer & Senior Vice President at Merck & Co., Inc. from 2018 to 2024.
Education includes an MBA from The Leonard N Stern School of Business and an undergraduate degree from Warrington College of Business Administration.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BEONE MEDICINES LTD. 0,03 % | 11/06/2026 | 397 891 ( 0,03 % ) | 9 M $ | 30/06/2026 |
Postes actifs de Aaron Rosenberg
| Sociétés | Poste | Début |
|---|---|---|
| BEIGENE LTD | Directeur Financier/CFO | 22/07/2024 |
| ARQULE, INC. | Directeur/Membre du Conseil | - |
| ACCELERON PHARMA INC. | Directeur/Membre du Conseil | 19/11/2021 |
| IMAGO BIOSCIENCES, INC. | Directeur/Membre du Conseil | 11/01/2023 |
| PROMETHEUS BIOSCIENCES, INC. | Directeur/Membre du Conseil | 16/06/2023 |
Harrisvaccines LLC
 Harrisvaccines LLC BiotechnologyHealth Technology Develops vaccine technology for the treatment and prevention of infectious diseases in swine and cattle | Directeur/Membre du Conseil | - |
Anciens postes connus de Aaron Rosenberg
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK & CO., INC. | Treasurer | 01/07/2024 |
Formation de Aaron Rosenberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Harrisvaccines LLC
Harrisvaccines LLC BiotechnologyHealth Technology Develops vaccine technology for the treatment and prevention of infectious diseases in swine and cattle | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Warrington College of Business Administration
 Warrington College of Business Administration Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
